[PLX] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -156.82%
YoY- 38.26%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 5,846 3,707 3,359 5,390 1,132 3,184 0 -
PBT -3,820 -8,010 -5,747 -5,479 0 0 0 -
Tax 17 49 0 -81 108 -374 -152 -
NP -3,820 -8,010 -5,747 -5,479 -8,875 -2,474 -5,894 -6.96%
Tax Rate - - - - - - - -
Total Cost 9,666 11,717 9,106 10,869 10,007 5,658 5,894 8.58%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin -65.34 -216.08 -171.09 -101.65 -784.01 -77.70 0.00 -
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS -0.04 -0.09 -0.06 -0.06 -0.10 -0.03 -0.08 -10.90%
EPS Diluted -0.04 -0.09 -0.06 -0.06 -0.10 -0.03 -0.08 -10.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.